The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Belova A.N.

Privolzhsky Research Medical University

Solovieva V.S.

City Clinical Hospital No. 3

Rasteryaeva M.V.

Privolzhsky Research Medical University

Belova E.M.

City Clinical Hospital No. 3

Multifocal inflammatory levamisole-induced leukoencephalopathy

Authors:

Belova A.N., Solovieva V.S., Rasteryaeva M.V., Belova E.M.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(7‑2): 89‑96

DOI: 10.17116/jnevro202012007289

Read: 5259 times

Download PDF (RU)
Contact the author
Table of contents

MULTIFOCAL INFLAMMATORY LEVAMISOLE-INDUCED LEUKOENCEPHALOPATHY
MULTIFOCAL INFLAMMATORY LEVAMISOLE-INDUCED LEUKOENCEPHALOPATHY

To cite this article:

Belova AN, Solovieva VS, Rasteryaeva MV, Belova EM. Multifocal inflammatory levamisole-induced leukoencephalopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(7‑2):89‑96. (In Russ.)
https://doi.org/10.17116/jnevro202012007289

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Dermatofibroma and keloid scar: simi­larities and differences. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(5):558-564
Low-level laser therapy in multiple scle­rosis: justification and opti­mization methods of application. (Literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(5):45-56
Glial fibrillary acidic protein: is there a rela­tionship with the course of multiple scle­rosis and traumatic brain injury before the onset of multiple scle­rosis?. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):80-84
An indi­vidual approach to the diagnosis and treatment of an acute psychotic condition in a patient with a multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):97-102
Surgical treatment of seco­ndary trigeminal neuralgia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):203-209
Quality of life of patients with multiple scle­rosis in the Smolensk region. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):36-40
Hormonal contraception methods and multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):24-30
Epidemiology of multiple scle­rosis in the city of Novo­sibirsk. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):119-127
Comparing the effi­cacy of divo­zilimab and second-line treatments for rela­psing-remitting multiple scle­rosis in the Russian Fede­ration: a systematic review and network meta-analysis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):58-68
Modern approaches to cystic lung diseases diagnosis. Journal of Respiratory Medi­cine. 2025;(1):30-37
Abstract:

Levamisole (L) is an anthelmintic agent that is widely used in clinical practice. L can enter the human organism during the treatment of helminthiasis as well as during the using the contaminated cocaine. Multifocal inflammatory levamisole-induced leukoencephalopathy (MILL) is one of the most serious complications of L use. The article discusses the clinical and radiological features of MILL which have a number of similarities of multiple sclerosis (MS) appearance. The disease has a favorable prognosis if started early, but the diagnosis of this rare form of leukoencephalopathy can cause difficulties. The case of MILL in patient with mistaken diagnosis of MS is descrThe case of MILL in patient with mistaken diagnosis of MS is descraibed.ibed.

Keywords:

levamisole
leukoencephalopathy
multiple sclerosis
differentiation

Authors:

Belova A.N.

Privolzhsky Research Medical University

Solovieva V.S.

City Clinical Hospital No. 3

Rasteryaeva M.V.

Privolzhsky Research Medical University

Belova E.M.

City Clinical Hospital No. 3

Received:

14.05.2020

Accepted:

18.05.2020

Close metadata

References:

  1. Lucia P, Pocek M, Passacantando A, Sebastiani ML, De Martinis C. Multifocal leucoencephalopathy induced by levamisole. Lancet. 1996;348:1450. https://doi.org/10.1016/S0140-6736(04)70094-X
  2. Sariaslani P, Ghanbarin A, Ghanbari P. Multifocal inflammatory leukoencephalopathy induced by accidental consumption of levamisole: A case report. Ir J Neurol. 2012;11(2):65-69. PMCID: PMC3829248.
  3. Li S, Manyevitch R, Sedaliu K, Abdelbaki A, Gupta N, Kumar A, Kumar Y, Rosovsky M. Cocaine abuse: Longitudinal MR imaging of lasting diffused leukoencephalopathy. Neuroradiol J. 2018;31(2):186-189.  https://doi.org/10.1177/1971400918757090
  4. Popova EV, Bruchov VV, Konovalova OE, Sharanova SN, Krotenkova MV, Boyko AN. Levamisol-induced acute demyelinating process in CNS. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2018;118(2):154. (In Russ.). https://doi.org/10.17116/jnevro2018118082128
  5. Krotenkova IA, Bruchov VV, Konovalov RN, Zacharova MN. MRI in differential diagnosis of MS and other demyelinating diseases. Vest rent radiol. 2019;100(4):229-236.  https://doi.org/10.20862/0042-4676-2019-100-4
  6. Shavlovskaya OA. Levamisol-induced leukoencephalopathy: clinical case. Annals of clinical and experimental neurology. 2018;12(3):75-80. (In Russ.). https://doi.org/10.25692/ACEN.2018.3.10
  7. Larocque A, Hoffman, RS. Levamisole in cocaine: unexpected news from an old acquaintance. Clin Toxicol. 2012;50:231-241.  https://doi.org/10.3109/15563650.2012.665455
  8. Czeto CC, Gillespie KM, Mathieson PW. Levamisole induces interleukin-18 and shifts type 1/type 2 cytokine balance. Immunology. 2000;100:217-224.  https://doi.org/10.1046/j.1365-2567.2000.00042.x
  9. Kayatas M. Levamisole treatment enhances protective antibody response to hepatitis B vaccination in hemodialysis patients. Artif Organs. 2002;26:492-496.  https://doi.org/10.1046/j.1525-1594.2002.06928.x
  10. Wu VC, Huang JW, Lien HC, Hsieh ST, Liu HM, Yang CC, Lin YH, Hwang JJ, Wu KD. Levamisole-induced multifocal inflammatory leukoencephalopathy: clinical characteristics, outcome, and impact of treatment in 31 patients. Medicine (Baltimore). 2006;85:203-213.  https://doi.org/10.1097/01.md.0000230250.95281.60. PMID: 16862045.
  11. Massaro AR, Cioffi RP, Laudisio A, Schiavino D, Mariani M. Four year double-blind controlled study of levamisole in multiple sclerosis. Ital J Neurol Sci. 1990;11(6):595-599.  https://doi.org/10.1007/BF02337444
  12. Vonmoos M, Hirsiger S, Preller KH, Hulka LM, Allemann D, Herdener M, Baumgartner MR, Quednow BB. Cognitive and neuroanatomical impairments associated with chronic exposure to levamisole-contaminated cocaine. Transl Psychiatry. 2018;27:8(1):235-262.  https://doi.org/10.1038/s41398-018-0279-3
  13. EI Kallab K, El Khoury J, Elias E, Chelala A. Encephalopathy induced by antihelminthic use of levamisole: report of two patients. J Med Liban. 2003;51(4):221-227. PMID: 15623138.
  14. Chethan GE, Kumar De U, Garkhal J, Sircar S, Malik YPS, Sahoo NR, Abhishek, Verma MR. Immunomodulating dose of levamisole stimulates innate immune response and prevents intestinal damage in porcine rotavirus diarrhea: a restricted-randomized, single-blinded, and placebo-controlled clinical trial. Trop Anim Health Prod. 2019;51(6):1455-1465. https://doi.org/10.1007/s11250-019-01833-1
  15. Buchanan JA, Heard K, Burbach C, Wilson ML, Dart R. Prevalence of levamisole in urine toxicology screens positive for cocaine in an inner-city hospital. JAMA. 2011;305:1657-1658. https://doi.org/10.1001/jama.2011.531
  16. Eiden C, Diot C, Mathieu O, Mallaret M, Peyriere H. Levamisoleadulterated cocaine: what about in European countries? J Psychoact Drugs. 2014;46:389-392.  https://doi.org/10.1080/02791072.2014.959215
  17. Pessini LM, Kremer S, Auger C, Castilló J, Pottecher J, de Sèze J, Lhermitte B, Maciag E, Rovira A. Tumefactive inflammatory leukoencephalopathy in cocaine users: Report of three cases. Mult Scler Relat Disord. 2019;38:101496. https://doi.org/10.1016/j.msard.2019.101496
  18. Zimmermann ZJ, Gauvin DV, Poling A. Discriminative stimulus effects of cocaine-levamisole combinations in Sprague-Dawley rats. J Psychopharmacol. 2018;32:900-910.  https://doi.org/10.1177/0269881118773545
  19. Kudlacek O, Hofmaier T, Luf A, Mayer FP, Stockner T, Nagy C, Holy M, Freissmuth M, Schmid R, Sitte HH. Cocaine adulteration. J Chem Neuroanat. 2017;83-84:75-81.  https://doi.org/10.1016/j.jchemneu.2017.06.001
  20. Hofmaier T, Luf A, Seddik A, Stockner T, Holy M, Freissmuth M, Ecker GF, Schmid R, Sitte HH, Kudlacek O. Aminorex, a metabolite of the cocaine adulterant levamisole,exerts amphetamine like actions at monoamine transporters. Neurochem Int. 2014;73:32-41.  https://doi.org/10.1016/j.neuint.2013.11.010
  21. Khan MS, Khan Z, Khateeb F, Moustafa A, Taleb M, Yoon Y. Recurrent Levamisole-Induced Agranulocytosis Complicated by Bowel Ischemia in a Cocaine User. Am J Case Rep. 2018;19:630-633.  https://doi.org/10.12659/AJCR.908898
  22. Brunt TM, van den Berg J, Pennings E, Venhuis B. Adverse effects of levamisole in cocaine users: a review and risk assessment. Arch Toxicol. 2017;91:2303-2313. https://doi.org/10.1007/s00204-017-1947-4
  23. Vitt JR, Brown EG, Chow DS, Josephson SA. Confirmed case of levamisole-associated multifocal inflammatory leukoencephalopathy in a cocaine user. J Neuroimmunol. 2017;305:128-130.  https://doi.org/10.1016/j.jneuroim.2017.01.018
  24. Kimmel DW, Wijdicks EF, Rodriguez M. Multifocal inflammatory leukoencephalopathy associated with levamisole therapy. Neurology. 1995;45:374-376.  https://doi.org/10.1212/wnl.45.2.374
  25. Zheng R. Differential diagnosis of delayed encephalopathy induced by anthelmintic imidazoles. Zhonghua Nei Ke Za Zhi. 1995;34:468-471. 
  26. Hook CC, Kimmel DW, Kvols LK, Scheithauer BW, Forsyth PA, Rubin J, Moertel CG, Rodriguez M. Multifocal inflammatory leukoencephalopathy with 5-fluorouracil and levamisole. Ann Neurol. 1992;31:262-267.  https://doi.org/10.1002/ana.410310306
  27. Kimmel DW, Schutt AJ. Multifocal leukoencephalopathy: occurrence during 5-fluorouracil and levamisole therapy and resolution after discontinuation of chemotherapy. Mayo Clin Proc. 1993;68:363-365.  https://doi.org/10.1016/S0025-6196(12)60132-3
  28. Fassas AB, Gattani AM, Morgello S. Cerebral demyelination with 5-fluorouracil and levamisole. Cancer Invest. 1994;12(4):379-383.  https://doi.org/10.3109/07357909409038226
  29. Savarese DM, Gordon J, Smith TW, Litofsky NS, Licho R, Ragland R, Recht L. Cerebral demyelination syndrome in a patient treated with 5-fluorouracil and levamisole. The use of thallium SPECT imaging to assist in noninvasive diagnosis — a case report. Cancer. 1996;77(2):387-394. https://doi.org/10.1002/(SICI)1097-0142(19960115)77:2<387::AID-CNCR23>3.0.CO;2-X "> 3.0.CO;2-X" target="_blank">https://doi.org/10.1002/(SICI)1097-0142(19960115)77:2<387::AID-CNCR23>3.0.CO;2-X
  30. Bozik ME, Gilbert MR. The role of levamisole in 5-fluorouracil levamisole-associated multifocal leukoencephalopathy. Ann Neurol. 1994;36:295. 
  31. Chen TC, Hinton DR, Leichman L, Atkinson RD, Apuzzo ML, Couldwell WT. Multifocal inflammatory leukoencephalopathy associated with levamisole and 5-fluorouracil: case report. Neurosurgery. 1994;35:1138-1142. https://doi.org/10.1227/00006123-199412000-00019
  32. Yeo W, Tong MM, Chan YL. Multifocal cerebral demyelination secondary to fluorouracil and levamisole therapy. J Clin Oncol. 1999;17(1):431-433. PMID: 10458263.
  33. Israel ZH, Lossos A, Barak V, Soffer D, Siegal T. Multifocal demyelinative leukoencephalopathy associated with 5-fluorouracil and levamisole. Acta Oncologica. 2000;39:117-120.  https://doi.org/10.1080/028418600431085. PMID: 10752665.
  34. Cheng YC, Po HL. Leukoencephalopathy after levamisole for the treatment of verrucae. Acta Neurol Taiwan. 2011;20:262-266. PMID: 22315177.
  35. Xu N, Zhou W, Li S, Zhou G, Zhang N, Liang J. Clinical and MRI characteristics of levamisole-induced leukoencephalopathy in 16 patients. J Neuroimaging. 2009;19(4):326-331.  https://doi.org/10.1111/j.1552-6569.2008.00344.x
  36. Long L, Song Y, Xu L, Xiao B. Levamisole-induced leukoencephalopathy mimicking Baló disease. Neurology. 2015;84:328.  https://doi.org/10.1212/WNL.0000000000001150
  37. Vosoughi R. Multifocal leukoencephalopathy in cocaine users: a report of two cases and review of the literature. BMC Neurol. 2015;15:208-214.  https://doi.org/10.1186/s12883-015-0467-1
  38. Chang HP, Kuo HC, Yen TC, Huang CC. Multifocal demyelinating leukoencephalopathy induced by Levamisole therapy. Chang Gung Med J. 2006;29(suppl):90-96. 
  39. Lucchinetti CF, Kimmel DW, Pavelko K, Rodriguez M. 5-Fluorouracil and levamisole exacerbate demyelination in susceptible mice infected with Theiler’s virus. Exp Neurol. 1997;147:123-129.  https://doi.org/10.1006/exnr.1997.6598
  40. Witonsky S, Buechner-Maxwell V, Santonastasto A, Pleasant R, Werre S, Wagner B, Ellison S, Lindsay D. Can levamisole upregulate the equine cell-mediated macrophage (M1) dendritic cell (DC1) T-helper 1 (CD4 Th1) T-cytotoxic (CD8) immune response in vitro? J Vet Intern Med. 2019;33(2):889-896.  https://doi.org/10.1111/jvim.15404
  41. Melnikov MV, Paschenkov MV, Boyko AN. Dendritic cells in multiple sclerosis. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2017;117(2. Vyp. 2):22-30. (In Russ.). https://doi.org/10.17116/jnevro20171172222-30
  42. Wojkowska DW, Szpakowski P, Glabinski A. Interleukin 17A Promotes Lymphocytes Adhesion and Induces CCL2 and CXCL1 Release from Brain Endothelial Cells. Int J Mol Sci. 2017;18(5). pii: E1000. https://doi.org/10.3390/ijms18051000
  43. Cascio MJ, Jen KY. Cocaine/levamisole-associated autoimmune syndrome: a disease of neutrophil-mediated autoimmunity. Curr Opin Hematol. 2018;25(1):29-36.  https://doi.org/10.1097/MOH.0000000000000393
  44. Yan R, Wu Q, Ren J, Cui H, Zhai K, Zhai Z, Duan Q. Clinical features and magnetic resonance image analysis of 15 cases of demyelinating leukoencephalopathy induced by levamisole. Exp Ther Med. 2013;6:71-74.  https://doi.org/10.3892/etm.2013.1077
  45. Blanc PD, Chin C, Lynch KL. Multifocal inflammatory leukoencephalopathy associated with cocaine abuse: is levamisole responsible? Clin Toxicol. 2012;50:534-535.  https://doi.org/10.3109/15563650.2012.692794
  46. Schwarz S, Mohr A, Knauth M, Wildemann B, Storch-Hagenlocher B. Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology. 2001;56:1313-1318. https://doi.org/10.1212/wnl.56.10.1313
  47. Gilbert JW. Comment on Xu N, Zhou W, Li S, Zhou G, Zhang N, Liang J. Clinical and MRI characteristics of Levamisole-induced leukoencephalopathy in 16 patients. J Neuroimaging. 2011;21:e188. https://doi.org/10.1111/j.1552-6569.2010.00466.x. PMID: 20136695.
  48. Bianco F, Iacovelli E, Tinelli E, Lepre C, Pauri F. Recurrent leukoencephalopathy in a cocaine abuser. Neurotoxicology. 2011;32:410-412.  https://doi.org/10.1016/j.neuro.2011.03.005
  49. González-Duarte A, Williams R. Cocaine-induced recurrent leukoencephalopathy. Neuroradiol J. 2013;26:511-513.  https://doi.org/10.1177/197140091302600503
  50. Sagduyu Kocaman A, Yalinay Dikmen P, Karaarslan E. Cocaine-induced multifocal leukoencephalopathy mimicking Balo’s concentric sclerosis: A 2-year follow-up with serial imaging of a single patient. Mult Scler Relat Disord. 2018;19:96-98.  https://doi.org/10.1016/j.msard.2017.11.011
  51. Hantson P, Di Fazio V, Del Mar Ramirez Fernandez M, Samyn N, Duprez T, van Pesch V. Susac-like syndrome in a chronic cocaine abuser: could levamisole play a role? J Med Toxicol. 2015;11(1):124-128.  https://doi.org/10.1007/s13181-014-0422-3
  52. Delattre JY, Krol G, Thaler HT, Posner JB. Distribution of brain metastases. Arch Neurol. 1988;45:741-744.  https://doi.org/10.1001/archneur.1988.00520310047016
  53. Liu HM, Hsieh WJ, Yang CC, Wu VC, Wu KD. Leukoencephalopathy induced by levamisole alone for the treatment of recurrent aphthous ulcers. Neurology. 2006;67:1065-1067. https://doi.org/10.1212/01.wnl.0000237344.06122.79. PMID: 17000980.
  54. Luppi G, Zoboli A, Barbieri F, Crisi G, Piccinini L, Silingardi V. Multifocal leukoencephalopathy associated with 5-fluorouracil and levamisole adjuvant therapy for colon cancer. A report of two cases and review of the literature. Ann Oncol. 1996;7:412-415.  https://doi.org/10.1093/oxfordjournals.annonc.a010610
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.